Latest Drug-eluting stent Stories
These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/
Supera Stent Addresses Growing Need in the U.S.
Post-Market Registry to Evaluate Long-Term Safety and Performance in Routine Practice HONG KONG, March 28, 2014 /PRNewswire/ -- OrbusNeich today announced the completion of enrollment
Newest Bare Metal Stent Technology Features Advanced Architecture and Provides Physicians with Enhanced Treatment Option for Patients NATICK, Mass., March 12, 2014 /PRNewswire/ --
Increasing Presence of Domestic Competitors Will Undercut Prices Set by Multinational Companies, According to Findings from Decision Resources Group BURLINGTON, Mass., March 6, 2014
-- Rapid polymer absorption within three months coupled with drug delivery profile up to nine months provides for excellent healing -- DURHAM, N.C., March 5, 2014 /PRNewswire/ ---
Company Initiates Joint U.S. and Japanese Registration Trial HONG KONG, Feb.
The current issue of the Journal of Endovascular Therapy offers results of a prospective study seeking to establish the rate of 1-year restenosis in diabetic patients with femoropopliteal in-stent
More Images (2 images) »